Vivos Therapeutics, Inc. (VVOS) Net margin 2019–2025
Vivos Therapeutics, Inc. (VVOS) net profit margin by fiscal year — reported net income divided by reported revenue.
-121.4%FY2025 · since FY2019: -94.4% → -121.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -121.4% | -47.3 pp |
| FY2024 | -74.1% | +24.3 pp |
| FY2023 | -98.4% | +50.4 pp |
| FY2022 | -148.8% | -28.7 pp |
| FY2021 | -120.2% | -27.9 pp |
| FY2020 | -92.3% | +2.1 pp |
| FY2019 | -94.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice